| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 23 Oct 2024 | 15 Oct 2024 |
| Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve PFA Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company met in their meeting held on today i.e. Wednesday 23rd October 2024. 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th September 2024. The meeting commenced at 03:45 P.M. and concluded at 04:15.P.M. Kindly take the same on your record and oblige. Thanking You. (As Per BSE Announcement Dated on: 23/10/2024) | ||
| Board Meeting | 13 Aug 2024 | 30 Jul 2024 |
| Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve Pursuant to Regu lation 29 ofthe SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of t he Company will be held on Tuesday 13th August 2024 inter alia to consider following business. Please take the above intimation in your records. Thanking You. PFA (As per BSE Announcement Dated on 13/08/2024) | ||
| Board Meeting | 30 May 2024 | 22 May 2024 |
| Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Thursday 30th May 2024 at registered office of the company inter alia to consider following business. 1. Approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 3pt March 2024. 2. Any other matter which the Board may think fit. Please take the above intimation in your records. Thanking You. Audited Financial Results for the year ended on 31st March, 2024 (As Per BSE Announcement Dated on 30.05.2024) | ||
| Board Meeting | 13 Feb 2024 | 18 Jan 2024 |
| Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday February 13 2024 inter alia to approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2023 also transact other business activities. Please take the above intimation in your records. Thanking You. Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company met in their meeting held on today i.e. Tuesday 13th February 2024. 1.) Considered and approved Un-audited financial results for the quarter ended as on 31st December 2023. The meeting commenced at 04:00 P.M. and concluded at 04:30.P.M. Kindly take the same on your record and oblige. Thanking You (As per BSE Announcement Dated on 13/02/2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
